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The cDNA for the porcine type I regulatory subunit (RI) of the CAMP-dependent protein kinase (CAMP- 
PK) was cloned into two different bacterial expression vectors: pKK223 and pUC18. Recombinant RI was 
produced by bacteria transformed with either construct, and purified by affinity chromatography. Both the 
native Rr from the pKK223 construct and the Rt with an amino terminal extension of eight amino acids 
from the pUC18 construct were found to be completely native with regard to inhibition of the catalytic 
subunit activity and CAMP binding. 
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1. INTRODUCTION 
The CAMP-dependent protein kinase is an in- 
teresting enzyme, both in structure and function. 
The kinase is composed of two regulatory (R) 
subunits (either type I or type II) and two catalytic 
(C) subunits [l]. In the heterodimeric conforma- 
tion, R$Zz, the C subunit is completely inactive. 
Following the binding of CAMP by the regulatory 
subunits the C subunit is released and hence 
becomes catalytically active [2]. The R subunit 
thus carries out two unique functions in that it 
binds the C subunit with high affinity, thereby sup- 
pressing the catalytic activity of this subunit; and 
it binds CAMP with high affinity which results in 
a conformational change and release of the C 
subunit [3,4]. 
The functions of the R subunit are localised in at 
least two structural domains, i.e. CAMP binding 
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and C subunit binding regions [I ,5,6]. In addition 
the type I regulatory subunit (RI) appears to exist 
as a dimer held together by disulphide bonds be- 
tween Cys-50 in the amino-terminus of the protein 
[7]. In order to understand the functions of these 
various domains, and to determine the mechanism 
whereby CAMP binding in the carboxy-terminus of 
the protein can be transmitted to the amino- 
terminus, and hence reduce the affinity of R for C, 
we set up a bacterial expression system to produce 
recombinant RI. In this paper we describe two ex- 
pression systems which result in the biosynthesis of 
biologically active RI subunit. 
2. MATERIALS AND METHODS 
2.1. Materials 
The source of most materials used in this study 
has been described [8,9]. CAMP-agarose type III 
was obtained from Pharmacia and Affigel 10 from 
BioRad. Isopropylthiogalactoside (IPTG) was 
from BRL. 
2.2. Plasmids and bacterial strains 
Plasmid pRr15 which contains the full length 
cDNA of porcine RI in pBR322 [9] was used for 
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the construction of the expression vectors and the 
JM103 strain of E. coli was used for transfor- 
mation. 
2.3. DNA sequencing 
DNA sequencing was performed using the 
Sanger dideoxy chain termination method [lo]. 
2.4. Purification of proteins and preparation of 
antisera 
The RI and C subunits were purified from rabbit 
and bovine skeletal muscle respectively, by 
published procedures [l I]. Antisera to the bovine 
skeletal muscle RI was prepared as described [ 111. 
Affinity purified antisera to RI were prepared by 
passage over columns of RI covalently attached to 
agarose (Affigel 10). Bound antisera were eluted 
using 6 M urea and dialyzed immediately into 
10 mM Mes-NaOH, pH 6.9, 1 mM EDTA and 
150 mM NaCl. 
2.5. Western blot analysis 
Crude cell-free extracts, or partially purified 
protein fractions were separated on 10% 
polyacrylamide gels containing 0.1% SDS. Follow- 
ing electrophoresis proteins were transferred to 
nitrocellulose using the methods of Towbin et al. 
[ 121. Nitrocellulose filters were blocked using 3% 
(w/v) BSA and 3% (w/v) ovalbumin in TBS. 
Recombinant RI was detected using affinity 
purified antisera (prepared as described above) 
followed by incubation with ‘251-labelled protein 
A. Following washing the blots were subjected to 
autoradiography at -70°C with two intensifying 
screens. 
2.6. Assay of the CAMP-dependent protein kinase 
C subunit activity was determined using the pep- 
tide assay (Kemptide) as described [l 1,131. To 
assay for R subunit activity, purified rabbit 
skeletal muscle C subunit (10 ~1) was preincubated 
with protein fractions (10~1) containing the 
recombinant RI, and then added to the kinase 
assay mix. Typically the kinase reaction was 
started by the addition of [y-“P]ATP and in- 
cubated at 30°C for 10 min prior to termination by 
spotting the reaction mix onto P-81 paper followed 
by washing with 0.5% (v/v) phosphoric acid. The 
C subunit was purified from rabbit skeletal muscle 
as described in [ 111. 
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2.7. Isolation of recombinant RI 
For the isolation of recombinant RI produced by 
pKK233 and pUC18 constructs, cultures of JM103 
were grown in LB broth containing 1 mM IPTG 
for 20 h at 37°C. Cell-free extracts were prepared 
by treatment of cell pellets with lysozyme 
(10 mg.ml-‘) in the presence of 0.2% Triton 
X-100, 10 mM Mes-NaOH, pH 6.9, followed by 
sonication (3 x 60 s). Cell debris was removed by 
centrifugation at 20000 x g for 30 min at 4°C and 
the resulting supernatant was applied directly to a 
CAMP-agarose affinity column (1 x 2 cm) 
previously equilibrated with 10 mM Mes-NaOH, 
pH 6.9, 1 mM EDTA, 150 mM NaCl and 0.2% 
Triton X-100. The column was then washed exten- 
sively with 2 M NaCl in 10 mM Mes-NaOH, pH 
6.9, 1 mM EDTA. The bound R subunits were 
eluted by incubation of the column at room 
temperature for 2 h in the presence of 5 mM 
CAMP in 10 mM Mes-NaOH, pH 6.9, 1 mM 
EDTA. Following elution the RI subunits were 
dialyzed extensively against 10 mM Mes-NaOH, 
pH 6.9, 1 mM EDTA, 150 mM NaCl. Preparation 
of CAMP free recombinant RI subunit was carried 
out as follows. The extensively dialyzed material 
from the CAMP-agarose column was made up to 
6 M urea by the addition of solid urea and allow 
to sit on ice for 30 min. This material was then 
dialyzed extensively against 10 mM Mes-NaOH, 
pH 6.9, 1 mM EDTA, 150 mM NaCl. In order to 
obtain homogeneous preparations of recombinant 
RI the protein was subjected to ion-exchange 
chromatography on a Mono Q column (Phar- 
macia). 
2.8. Protein estimation 
Protein was estimated by the method of Brad- 
ford [ 141 using BSA as a standard. 
3. RESULTS AND DISCUSSION 
3.1. Construction of RI expression vectors 
The cDNA for the porcine RI, pR115, which con- 
tains the complete coding region for the protein [9] 
was used for all the constructions described below. 
The 1426 bp ECORI fragment of pR115, which ex- 
tends 70 bp 5’ of the initiator methionine and 
200 bp past the TGA terminator codon was 
isolated, and then partially digested with Ncol 
(fig.la). The 1350 bp NcoI-ECORI fragment was 
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Fig.1. Construction qf bacterial expression vectors for 
porcine Rr. (a) Isolation of the Rt coding sequences. The 
1426 bp cDNA for the porcine RI was digested with 
EcoRr followed by partial digestion with NcoI. The 
1350 bp fragment (f1350) which starts at the initiator 
methionine was isolated, treated with Klenow and used 
for the addition of linkers. Finally the 1350 bp fragment 
was ligated into the pKK223-2 and pUC18 vectors. (b) 
Sequence of the expression vectors pKK-RI and pUC-RI 
showing the position of the Shine and Delgano sequence 
relative to the initiator methionine. Restriction 
endonuclease sites are indicated, as is the Shine and 
Dalgarno sequence, which is underlined and denoted by 
S/D. 
subsequently blunt ended and ECORI linkers, 
GGAATTCC and CCCGAATTCGGG, were add- 
ed to produce f1350EI and f1350EI1, respectively. 
The fragments 1350EI and 1350EII were subse- 
quently ligated into the lac based vectors pKK233 
[15-171 and pUC18 [18], respectively. The DNA 
sequence at the 5 ‘-region with respect to the vector 
sequences is shown in fig.lb. In the pKK-Rr con- 
struction the Shine and Dalgarno sequence is 12 bp 
upstream from the initiator methionine and hence 
the recombinant protein produced has no exten- 
sion of the amino-terminus, and is therefore 
‘native’. The pUCRr construct produces a protein 
which contains an extension of eight amino acids 
at the amino-terminus (fig.lb). 
Both constructs were used to transform bacterial 
strain JM103 and several clones were obtained 
with the RI cDNA in the correct orientation. 
3.2. Expression of porcine RI in bacteria 
Bacteria transformed with pKK-RI and pUC-RI 
were cultured and induced for 6 h or 20 h with 
1 mM IPTG. Cell-free extracts were prepared and 
analyzed by Western blotting using an affinity 
purified antisera to bovine RI [l 11. The results 
(fig.2) showed that both constructs produced im- 
munoreactive protein, and that the expression of 
recombinant Rr was tightly controlled in the case 
of the pKK-Rr construct. The pUC-Rr construct, in 
contrast, was somewhat leaky, resulting in the pro- 
duction of detectable cross-reacting material even 
in the absence of IPTG. However, with the pUC- 
RI construct much larger amounts of immunoreac- 
tive protein were detected following induction by 
IPTG. 
3.3. Purification of recombinant RI from pKK-RI 
and pUC-RI 
The recombinant Rr was purified from JM103 
cultures which had been induced by 1 mM IPTG 
for 16 h. Typically the cell pellet was disrupted by 
lysozyme/sonication treatment, centrifuged and 
directly applied to a CAMP-agarose affinity col- 
umn. Following extensive washing with 2 M NaCl 
the RI protein was eluted with 5 mM CAMP. This 
procedure usually produced a protein which was 
approx. 30-50% pure as judged by SDS-gel elec- 
trophoresis. It was subsequently purified to 
homogeneity using ion-exchange chromatography 
on a Mono Q column. Approx. 50-1OOpg of 
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Fig.2. Western blot analysis of recombinant Rt synthesis 
by pKK-Rr and pUC-Rt. Cultures of JM103 carrying 
pKK-Rr or pUC-Rr were grown to an A600 of 0.2, and 
then cultures allowed to grow for a further 6 h in- the 
presence or absence of 1 mM IPTG. Cell-free extracts 
were prepared and samples (50/g protein) analyzed by 
Western blotting using an affinity purified antibody to 
RI. Lanes: 1, JM103/pKK223 (+IPTG); 2, JM103/ 
pKK-R, (-IPTG); 3, JM103/pKK-R, (+IPTG); 4, 
JM103/pUC18 (+ IPTG); 5, JM103/pUC-R, (- IPTG); 
6, JM103/pUC-Rt (+ IPTG); 7, purified bovine Rt 
(0.06 pg protein). 
recombinant RI was obtained per liter from each of 
the two constructs. To obtain CAMP-free recombi- 
nant RI the protein was treated with 6 M urea for 
30 min and then dialyzed extensively. This pro- 
cedure resulted in the production of a biologically 
active protein (see below). 
3.4. Recombinant RI inhibits C subunit activity 
Preparations of recombinant RI from both con- 
structs were tested for their ability to inhibit the 
catalytic activity of the purified C subunit from 
rabbit skeletal muscle. Both RI preparations in- 
hibited C activity and in both cases the inhibition 
could be reversed by the addition of 10 yM CAMP 
to the assay mix (fig.3), indicating normal 
association-dissociation of the recombinant RI and 
the C subunit. 
This was further investigated by examining the 
80 . 
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Fig.3. Inhibition of C subunit by recombinant RI 
preparations from the pKK-RI and pUC-RI constructs. 
Assays were carried out as described in section 2. RI 
from the pKK-Rr construct in the absence of 10/M 
CAMP (0); RI from the pKK-RI construct in the 
presence of CAMP (0); Rr from the pUC-RI construct 
in the absence of CAMP (A); RI from the pUC-RI 
construct in the presence of CAMP (A). The protein 
concentration of recombinant Rt stock was lOpg/ml. 
Ka for activation of the holoenzyme formed from 
recombinant RI from the pUC-RI construct and 
rabbit skeletal muscle C subunit (fig.4). Half- 
maximal activation of the holoenzyme was ob- 
tained at 1 x lo-’ M CAMP, similar to that 
observed for the native porcine enzyme [19]. 
Recombinant Rr from the pKK-RI construct show- 
ed similar results (not shown). 
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Fig.4. Activation of holoenzyme formed from 
recombinant RI (pUC-Rr) and rabbit skeletal muscle C 
subunit by CAMP. Assays were carried out as detailed in 
section 2. 
4. CONCLUSIONS 
(i) The data presented in this paper demonstrate 
that recombinant RI subunit is biologically active. 
The fact that the protein produced by the 
pUC18-RI construct is fully active is interesting in 
that, in contrast to that from the pKK-RI con- 
struct, the Rr in this instance contains 8 amino 
acids at the NH2 terminus. This implies that N- 
terminals are probably not important for 
biological activity. 
(ii) These Rr expression systems will make it 
possible to probe structure-function relationships 
using site-directed mutagenesis. 
During the course of this work, Saraswat et al. 
[20] reported the expression of the bovine Rr 
subunit in E. cob. These workers also used a pUC 
construct producing a protein with an additional 
10 amino acids at the amino-terminus. 
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